This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chugh, S. S. Articles by Reinier, K. Search for Related Content PubMed PubMed Citation Articles by Chugh, S. S. Articles by Reinier, K. Related Collections Other diagnostic testing Arrhythmias, clinical electrophysiology, drugs Related Article

(Circulation. 2009;119:2863-2864.)
© 2009 American Heart Association, Inc.

Editorial

Predicting Sudden Death in the General Population

Another Step, N Terminal B-Type Natriuretic Factor Levels

Sumeet S. Chugh, MD; Kyndaron Reinier, PhD

From the Heart Institute, Cedars-Sinai Health System, Los Angeles, Calif.

Correspondence to Sumeet S. Chugh, MD, The Heart Institute, 5702 S Tower, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048. E-mail sumeet.chugh@cshs.org

Key Words: Editorials • death, sudden • risk factors

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Despite increased awareness and advances in resuscitation methodology, the average national survival from sudden cardiac arrest in North America remains 4.5%, ranging from 1.1% in the state of Alabama to 8.1% in Seattle, Wash.¹ Given this 95% probability of instantaneous death once cardiac arrest occurs, the pursuit to identify effective preventive interventions must be unrelenting. The implantable cardioverter-defibrillator has been an effective modality that treats the crisis, but methodologies for effective risk stratification of the actual condition continue to elude us.² The left ventricular ejection fraction can be a reasonable means of risk stratification in a subgroup of sudden cardiac death (SCD) patients but is clearly an inadequate predictor of overall risk.³ Some mechanisms of SCD risk are likely to overlap between men and women,⁴ but there is growing evidence to suggest that there may also be sex-specific pathways leading to ventricular arrhythmogenesis.^5,6 A recent study in a Medicare population sample (1991 to 2005) found that men were significantly more likely to undergo cardioverter-defibrillator implantation for both primary and secondary prevention of SCD (hazard ratio 3.15, 95% confidence interval 2.86 to 3.47, and hazard ratio 2.44, 95% confidence interval 2.30 to 2.59, respectively),⁷ and this disparity between the sexes has also been reported in 2 other studies.^8,9 Therefore, the identification of sex-specific SCD mechanisms is a crucial element in the quest for enhancing risk stratification.

Article see p 2868

B-type natriuretic peptide (BNP) is preferentially synthesized and secreted from the ventricles (as opposed to the atria) but can be secreted . . . [Full Text of this Article]

Related Article:

Amino-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein as Predictors of Sudden Cardiac Death Among Women

Ethan C. Korngold, James L. Januzzi, Jr, Mary Lou Gantzer, M.V. Moorthy, Nancy R. Cook, and Christine M. Albert
Circulation 2009 119: 2868-2876. [Abstract] [Full Text]